The following discussion should be read in conjunction with our audited financial statements and the related notes that appear elsewhere in this annual report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to those discussed below and elsewhere in this annual report.
Our audited financial statements are stated in
Results of Operations
The following summary of our results of operations should be read in conjunction
with our financial statements for the year ended
We had revenues of
Year EndedApril 30, 2022 Compared to Year EndedApril 30, 2021 Year Ended April 30, 2022 2021 Changes % Revenues$ 1,162,822 $ 826,731 $ 336,091 41 % Cost of revenue (1,143,947 ) (731,251 ) (412,696 ) 56 % Gross Profit 18,875 95,480 (76,605 ) 80 % Operating Expenses (29,279,447 ) (852,808 ) (28,426,639 ) 3,333 % Loss from Operations (29,260,572 ) (757,328 ) (28,503,244 ) 3,764 % Other Expenses (329,884 ) - (329,884 ) 0 % Net Loss$ (29,590,456 ) $ (757,328 ) $ (28,833,128 ) 3,807 %
Our audited financial statements report a net loss of
During the year ended
Our operating expenses for the year ended
During the year ended
18 Table of Contents
Liquidity and Financial Condition
Working Capital April 30, April 30, 2022 2021 Current Assets$ 449,614 $ 19,659 Current Liabilities$ 1,146,362 $ 224,142 Working Capital (Deficiency)$ (696,748 ) $ (204,483 )
Our total current assets as of
Our total current liabilities as of
Our working capital deficit at
Cash Flows Year EndedApril 30, 2022 2021
Cash Flows used in Operating Activities
(21,310 ) (5,719 )
Cash Flows provided by Financing Activities 426,403 287,680
Net increase (decrease) in cash during period
Operating Activities
Net cash used in operating activities was
During the year ended
During the year ended
Investing Activities
During the year ended
Financing Activities
During the year ended
19 Table of Contents Cash Requirements
As of
We will require additional funds for our budgeted expenses over the next 12 months. These funds may be raised through equity financing, debt financing, or other sources, which may result in further dilution in the equity ownership of our shares. There is still no assurance that we will be able to maintain operations at a level sufficient for an investor to obtain a return on his investment in our common stock. Further, we may continue to be unprofitable. We need to raise additional funds in the immediate future in order to proceed with our budgeted expenses.
Specifically, based on nominal operations we estimate our operating expenses and working capital requirements for the next 12 months to be as follows:
Estimated Description Expenses ($) Public Company + Professional Fees$ 190,000 General & Administrative Expense$ 400,000 Marketing Expenses$ 600,000 Initial Personnel$ 210,000 HealthGPO$ 25,000 cbdGPO$ 55,000 GPO PAY - Portal Development$ 12,000 GPO Distro$ 140,000
$ 1,692,000
We will require additional financing in order to enable us to proceed with our
plan of operations, as discussed above, including approximately
20 Table of Contents
We anticipate continuing to rely on equity sales of our common stock in order to continue to fund our business operations. Issuances of additional shares will result in dilution to our existing stockholders. There is no assurance that we will achieve any additional sales of our equity securities or arrange for debt or other financing to fund our planned business activities. We presently do not have any arrangements for additional financing for the expansion of our future operations, and no potential lines of credit or sources of financing are currently available for the purpose of proceeding with our plan of operations. If we are not successful in raising sufficient capital to execute our business plan, we will be required to scale down or delay our plan of operation to accommodate our available resources.
Contractual Obligations
Not required for smaller reporting companies
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.
Critical Accounting Policies
The preparation of financial statements in accounting principles generally
accepted in
Revenue Recognition
During the year ended
Step 1: Identify the contract(s) with customers - The invoice has been generated and provided to the customer.
Step 2: Identify the performance obligations in the contract - The performance obligations of delivery of products are stated in the invoice.
Step 3: Determine the transaction price - The transaction price has been identified in the invoice.
Step 4: Allocate the transaction price to performance obligations - The Company has allocated the transaction price to performance obligation in the invoice.
Step 5: Recognize revenue when the entity satisfies a performance obligation - The Company has shipped out the product and, therefore, satisfied the performance obligation.
The Company engages in the business of organizing, promoting, and operating industry-specific group purchase organizations (GPOs). A GPO is an entity created to leverage the purchasing power of a group of businesses (or individuals) to obtain discounts from vendors. The Company identifies underserved markets, segments and industries where there is little to no competition and develops specific GPOs around them. The Company develops industry specific GPO that leverage the aggregated purchasing power of its members. The GPOs use collective buying power to obtain and negotiate discounts on products and services from vendors. The discounted rates are then shared with its members saving them money and time by also improving supply chain efficiencies.
The Company is comprised of HealthGPO, a
During the year ended
21 Table of Contents
HealthGPO works with companies that have well priced high-quality products and services with advantageous terms. The Company's primary offerings are volume supply acquisitions, access to quality personal protective equipment (PPE), essential necessities and medical equipment from non-traditional, yet fully accredited suppliers. Additionally, the Company identify "best of breed" products that have a unique value proposition and become distributors with some form of exclusivity and/or favorable terms. HealthGPO is developing a b2b healthcare portal to offer medical products to everyday business. Technology will continue to play an important role in exceeding our stated goals.
HealthGPO also addresses the needs of individual consumers who want access to products at a good price that is typically only available to healthcare professionals. The Company intend on developing a b2c (business to consumer) portal to sell healthcare and wellness products directly to consumers.
Convertible Financial Instruments
The Company bifurcates conversion options from their host instruments and
accounts for them as free-standing derivative financial instruments if certain
criteria are met. The criteria include circumstances in which (a) the economic
characteristics and risks of the embedded derivative instrument are not clearly
and closely related to the economic characteristics and risks of the host
contract, (b) the hybrid instrument that embodies both the embedded derivative
instrument and the host contract is not remeasured at fair value under otherwise
applicable generally accepted accounting principles with changes in fair value
reported in earnings as they occur, and (c) a separate instrument with the same
terms as the embedded derivative instrument would be considered a derivative
instrument. An exception to this rule is when the host instrument is deemed to
be conventional, as that term is described under applicable
When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument.
Share-Based Compensation
The Company accounts for share-based compensation under the fair value method in accordance with ASC 718, "Compensation - Stock Compensation," which requires all such compensation to employees and non-employees to be calculated based on its fair value of the equity instrument at the grant date and recognized in the earnings over the requisite service or vesting period.
© Edgar Online, source